Worth reading
64In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.This transaction
Acquisition of shares and conversion into a subsidiaryCounterpartyMiyazaki Koji (宮崎 宏二), Hinagata Tatsuhiro (日永田 達弘)
Disclosing companyHuman Creation Holdings,Inc.
Execution Date / Effective Date1 July 2026 (completed)
Target company
Staffing services Recruitment services
Location Chuo-ku, TokyoShare capital ¥20 millionDate of incorporation 24 January 2014
Net Sales¥1,501 million (fiscal year ended March 2026)
Operating profit¥11 million (fiscal year ended March 2026)
Net income for the current fiscal year¥4 million (fiscal year ended March 2026)
Net assets¥176 million (fiscal year ended March 2026)
Impact on Business Performance
Currently under review
Procedures and assumptions
Management structure after acquisitionLife Shield will become a consolidated subsidiary of the Company. Other details, including the corporate name, representative and treatment of employees, are not disclosed.
| Item | Details |
|---|---|
| Transaction name | Acquisition of shares and conversion into a subsidiary |
| Counterparty name | Miyazaki Koji (宮崎 宏二), Hinagata Tatsuhiro (日永田 達弘) |
| Name of the Subject Company | 株式会社ライフシールド |
| Business Description of the Subject Company | Staffing services Recruitment services |
| Location of the Subject Company | Chuo-ku, Tokyo |
| Capital Stock of the Subject Company | ¥20 million |
| Date of Establishment of the Subject Company | 24 January 2014 |
| Net Sales of the Subject Company | ¥1,501 million (fiscal year ended March 2026) |
| Operating Profit of the Subject Company | ¥11 million (fiscal year ended March 2026) |
| Net Income of the Subject Company | ¥4 million (fiscal year ended March 2026) |
| Net Assets of the Subject Company | ¥176 million (fiscal year ended March 2026) |
| Number of shares acquired | All issued shares (number of shares: not disclosed) |
| Impact on Business Performance | Currently under review |
| Execution Date / Effective Date | 1 July 2026 (completed) |
| Management structure after acquisition | Life Shield will become a consolidated subsidiary of the Company. Other details, including the corporate name, representative and treatment of employees, are not disclosed. |
Items this document does not state (17)
Acquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodVoting rights ownership percentageFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Date of board resolutionContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to Execution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The transaction is intended to improve recruitment capabilities, utilization rates, operational efficiency and profitability, and to create new business opportunities by leveraging Life Shield's registered staff base of more than 20,000 people and customer base of approximately 400 companies, while deploying our Group's expertise in the recruitment and development of specialized personnel, sales management, corporate management, and IT and DX support.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.